144 related articles for article (PubMed ID: 7550317)
1. MSH2 deficient mice are viable and susceptible to lymphoid tumours.
Reitmair AH; Schmits R; Ewel A; Bapat B; Redston M; Mitri A; Waterhouse P; Mittrücker HW; Wakeham A; Liu B
Nat Genet; 1995 Sep; 11(1):64-70. PubMed ID: 7550317
[TBL] [Abstract][Full Text] [Related]
2. Mouse models for hereditary nonpolyposis colorectal cancer.
de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
[TBL] [Abstract][Full Text] [Related]
3. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
5. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.
Reitmair AH; Redston M; Cai JC; Chuang TC; Bjerknes M; Cheng H; Hay K; Gallinger S; Bapat B; Mak TW
Cancer Res; 1996 Aug; 56(16):3842-9. PubMed ID: 8706033
[TBL] [Abstract][Full Text] [Related]
7. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
8. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
10. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
[TBL] [Abstract][Full Text] [Related]
11. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
[TBL] [Abstract][Full Text] [Related]
12. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
Bubb VJ; Curtis LJ; Cunningham C; Dunlop MG; Carothers AD; Morris RG; White S; Bird CC; Wyllie AH
Oncogene; 1996 Jun; 12(12):2641-9. PubMed ID: 8700523
[TBL] [Abstract][Full Text] [Related]
14. [Recognising hereditary non-polyposis colorectal cancer without a clear family history].
de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325
[TBL] [Abstract][Full Text] [Related]
15. Genetic instability of microsatellites in hematological neoplasms.
Robledo M; Martinez B; Arranz E; Trujillo MJ; Gonzalez Ageitos A; Rivas C; Benitez J
Leukemia; 1995 Jun; 9(6):960-4. PubMed ID: 7596185
[TBL] [Abstract][Full Text] [Related]
16. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD
Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269
[TBL] [Abstract][Full Text] [Related]
17. Human mismatch repair genes and their association with hereditary non-polyposis colon cancer.
Kolodner RD; Hall NR; Lipford J; Kane MF; Rao MR; Morrison P; Wirth L; Finan PJ; Burn J; Chapman P
Cold Spring Harb Symp Quant Biol; 1994; 59():331-8. PubMed ID: 7587085
[No Abstract] [Full Text] [Related]
18. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.
de Wind N; Dekker M; Berns A; Radman M; te Riele H
Cell; 1995 Jul; 82(2):321-30. PubMed ID: 7628020
[TBL] [Abstract][Full Text] [Related]
19. Mammalian MutS homologue 5 is required for chromosome pairing in meiosis.
Edelmann W; Cohen PE; Kneitz B; Winand N; Lia M; Heyer J; Kolodner R; Pollard JW; Kucherlapati R
Nat Genet; 1999 Jan; 21(1):123-7. PubMed ID: 9916805
[TBL] [Abstract][Full Text] [Related]
20. Mismatch repair deficiency in phenotypically normal human cells.
Parsons R; Li GM; Longley M; Modrich P; Liu B; Berk T; Hamilton SR; Kinzler KW; Vogelstein B
Science; 1995 May; 268(5211):738-40. PubMed ID: 7632227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]